TOG Review (RCOG Journal)
MRCOG Part 2
Gynaecological Oncology
Cervical cancer elimination
Key Statistics
- <4/100,000 — Who elimination threshold
- 90–70–90 — 2030 Targets: Vaccination–screening–treatment
- 348,874 — Global cervical cancer deaths, 2022
Don't-miss facts
-
Elimination = <4/100,000; WHO 2030 targets 90% vaccinated – 70% screened – 90% treated
-
12 high-risk HPV types; 16/18 cause ~70% of cancers; single-dose nonavalent/bivalent vaccine (KEN-SHE, 97.5% efficacy) – NHS single-dose since Sept 2023
-
HPV primary testing sensitivity 89.9% vs cytology 72.9% for high-grade disease (ESTAMPA: cytology missed 52% of CIN3+ vs HPV 2%)
-
UK screening coverage 68.7% and falling; multi-level inequity in uptake (socioeconomic, ethnicity, disability, LGBTQ+, age, migrant status)
-
Self-sampling: YouScreen return 56% (opportunistic) vs 13% (postal); Dutch data show lower HPV/CIN3+ detection with self- vs clinician-sampling – equivalence not proven
-
LLETZ (excision, 7–25mm) ↑miscarriage/preterm birth (risk rises >10mm depth); ablative methods (cryotherapy, cold coagulation, laser) have no obstetric sequelae
-
ESTAMPA colposcopy: sensitivity 90.4%/specificity 50.1% for CIN2+, falling to 77.6% postmenopausally; 3 biopsies → 95.6% sensitivity vs 60.6% for 1
-
≥50% CIN2 regresses spontaneously in 2 years – conservative management viable in selected women <30y (6-monthly colposcopy up to 2 years)
Vaccine dose vs schedule
Single dose (KEN-SHE, 97.5% efficacy) – NHS standard since 2023 Multi-dose retained: immunocompromised individuals
Screen-triage-treat options (WHO)
Primary HPV test (sensitivity 89.9%) Cytology alone (sensitivity 72.9%, still used in 78% of programmes)
Abbreviation Key
- WHO — World Health Organization
- LLETZ — large loop excision of the transformation zone
- HPV — human papillomavirus
- AICCS — artificial intelligence cervical cytology system
- VLP — virus-like particle
- aOR — adjusted odds ratio
- CIN — cervical intraepithelial neoplasia
- RR — relative risk
- LMIC — low- and middle-income country
- OR — odds ratio
- HIC — high-income country
- CI — confidence interval
- LBC — liquid-based cytology
- NHS — National Health Service
- HC2 — hybrid capture 2 (HPV testing platform)
- GAVI — Global Alliance for Vaccines and Immunisation (the Vaccine Alliance)
- VIA — visual inspection with acetic acid
- UNICEF — United Nations Children's Fund
- VILI — visual inspection with Lugol's iodine
Source: Davies JC et al. Cervical cancer elimination: what, how and WHO? The Obstetrician & Gynaecologist 2025;27:241–251. doi:10.1111/tog.12984
MRCOG AI is an independent educational tool. It is not affiliated with, endorsed by, or connected to the Royal College of Obstetricians and Gynaecologists (RCOG).